This federal Project Grant award from the National Institute on Aging's Aging Research Program (CFDA 93.866) provides $468,534 to the University of Southern California to examine alcohol consumption as a risk factor for Alzheimer's disease and related dementias (ADRD). The 2-year study aims to delineate the relationship between midlife alcohol use and late-life ADRD diagnosis and onset, explore interactions with the APOE gene, and leverage the twin design of the Swedish Twin Registry to better...
This $377,227 Project Grant was awarded on August 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The prime awardee, Florida State University, will conduct research related to traumatic brain injury and psychological health. The funded project aims to develop innovative...
The federal Project Grant award of $509,979 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research by the University of North Carolina at Chapel Hill to develop "potentiated chip variants as therapeutics to alleviate tau pathology and neurodegeneration." The project aims to explore innovative approaches to treat neurodegenerative conditions relevant to military personnel and the general public....
The University of Alabama will receive $749,987 under a three-year Project Grant award from the Defense Health Agency to investigate the role of environmental stressors on veteran neurocognitive aging. The grant, issued under the Military Medical Research and Development program (CFDA 12.420), will support research from May 2023 to April 2026. The Military Medical Research and Development program aims to transform military and public health through innovative medical research. This award will...
This $1,200,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at the Medical University of South Carolina (MUSC) to target a novel adaptive stress response pathway for therapeutic intervention in alpha-synuclein-induced dementia. Through a sub-award to the Regents of the University of Minnesota, the project will utilize mouse models to provide detailed neuropathological analysis of alpha-synuclein pathology,...
This $1,525,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports foundational studies at the University of Florida to understand the phenotypic, region-specific, and cell-specific dysregulation in the central nervous system of individuals with myotonic dystrophy. The 4-year award, effective May 15, 2024, will enable the university to conduct innovative research to advance the understanding of this neurological...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
This $151,869 federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) funding opportunity, will support research to investigate the relationship between chronic alcohol consumption, metabolic dysfunction, and the progression of Alzheimer's disease (AD). The key objectives of this 2-year project are to: 1) assess the influence of chronic ethanol exposure on metabolic function and tau pathology in the...
This federal Project Grant award, valued at $1,078,882.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports a research project conducted by the Sanford Burnham Prebys Medical Discovery Institute (SBP) in La Jolla, CA. The project aims to investigate a "chemical engineering approach to ALS that amplifies a more sophisticated view of the multimodal therapeutic actions of donor and host neural stem cells in that...
The University of Florida Division of Sponsored Research was awarded a $745,408 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on April 1, 2024, will support research on the "Contribution of Repeat Associated Non-AUG (RAN) Proteins in Friedreich's and Other Hereditary Ataxias" over a 4-year period through March 31, 2028. This research aims to advance the understanding and...